Results 1 to 10 of about 465,548 (350)
Peripheral T-cell lymphoma, not otherwise specified
Journal of Family Medicine and Primary Care, 2017 The peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) belongs to a heterogeneous class of aggressive neoplasms. Although several morphologic subtypes of this tumor have been described, no particular genetic, immunological, or distinct ...
Kunal Kishor Jha +3 more
doaj +3 more sources
Therapeutic challenges in peripheral T-cell lymphoma
Molecular CancerPeripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of hematological malignancies. Compared to our knowledge of B-cell tumors, our understanding of T-cell leukemia and lymphoma remains less advanced, and a significant number of patients ...
Yunpeng Luan +10 more
doaj +2 more sources
Indolent peripheral T-cell lymphoma resembling Kimura's disease: a new variant of T-cell Lymphoma? [PDF]
Leukemia Research ReportsKimura's disease (KD) is a rare chronic inflammatory disorder of unknown etiology prevalent in middle-aged Asian males. Kimura's disease transforming to T-cell lymphoma or coexisting with T-cell lymphoma have not been reported in the scientific ...
Hui Sun +5 more
doaj +2 more sources
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Haematologica, 2018 Due to heterogeneous morphological and immunophenotypic features, approximately 50% of peripheral T-cell lymphomas are unclassifiable and categorized as peripheral T-cell lymphomas, not otherwise specified.
Meng-Meng Ji +13 more
doaj +2 more sources
Therapeutic options in peripheral T cell lymphoma
Journal of Hematology & Oncology, 2016 Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor prognosis. The standard first-line treatments have resulted in unsatisfactory patient outcomes.
Yaping Zhang +3 more
doaj +2 more sources
Pathogenesis of Peripheral T Cell Lymphoma.
Annual Review of Pathology: Mechanisms of Disease, 2018 Peripheral T cell lymphomas (PTCLs) are highly heterogeneous tumors, displaying distinct clinical and biological features. The pathogenesis and normal counterpart of such entities have been elusive for decades. Recent studies have, however, disclosed key mechanisms of peripheral T cell transformation, including (a) the deregulation of signaling ...
M. Pizzi +2 more
semanticscholar +4 more sources
Peripheral T cell lymphoma: Not otherwise specified
Indian Journal of Dermatology, 2015 Peripheral T cell lymphoma (PTCL) is a heterogeneous group of hematological tumors originating from mature T cells, which constitutes less than 15% of all non-Hodgkins lymphomas in adults.
Anusha H Pai +3 more
doaj +3 more sources
JAMA Network Open, 2021 Key Points Question Is allogeneic hematopoietic stem cell transplant (HSCT) or autologous HSCT more effective and safer for patients with refractory or relapsed peripheral T-cell lymphoma? Findings In this systematic review and meta-analysis of 30 trials
Jun Du +4 more
semanticscholar +1 more source
Genetic Landscape of Peripheral T-Cell Lymphoma
Life, 2022 Peripheral T-Cell lymphoma (PTCL) comprises a heterogenous group of uncommon lymphomas derived from mature, post-thymic or “peripheral” T- and natural killer cells. The World Health Organization (WHO) emphasizes a multiparameter approach in the diagnosis
Vivian Hathuc, Friederike Kreisel
doaj +1 more source
Peripheral T-cell lymphoma [PDF]
Cancer, 1989 Peripheral T-cell lymphoma is the most common type of T-cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T-cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4-97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the
James O. Armitage +10 more
openaire +2 more sources